A Retrospective Cohort Study of Oral Leukoplakia in Female Patients—Analysis of Risk Factors Related to Treatment Outcomes
Abstract
:1. Introduction
2. Materials and Methods
Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Abati, S.; Bramati, C.; Bondi, S.; Lissoni, A.; Trimarchi, M. Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis. Int. J. Environ. Res. Public Health 2020, 17, 9160. [Google Scholar] [CrossRef] [PubMed]
- Warnakulasuriya, S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009, 45, 309–316. [Google Scholar] [CrossRef]
- Shield, K.D.; Ferlay, J.; Jemal, A.; Sankaranarayanan, R.; Chaturvedi, A.K.; Bray, F.; Soerjomataram, I. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J. Clin. 2017, 67, 51–64. [Google Scholar] [CrossRef] [PubMed]
- de Vicente, J.C.; Donate-Perez Del Molino, P.; Rodrigo, J.P.; Allonca, E.; Hermida-Prado, F.; Granda-Diaz, R.; Rodriguez Santamarta, T.; Garcia-Pedrero, J.M. SOX2 Expression Is an Independent Predictor of Oral Cancer Progression. J. Clin. Med. 2019, 8, 1744. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Warnakulasuriya, S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2018, 125, 582–590. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ganesh, D.; Sreenivasan, P.; Ohman, J.; Wallstrom, M.; Braz-Silva, P.H.; Giglio, D.; Kjeller, G.; Hasseus, B. Potentially Malignant Oral Disorders and Cancer Transformation. Anticancer Res. 2018, 38, 3223–3229. [Google Scholar] [CrossRef] [Green Version]
- Speight, P.M.; Khurram, S.A.; Kujan, O. Oral potentially malignant disorders: Risk of progression to malignancy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2018, 125, 612–627. [Google Scholar] [CrossRef] [Green Version]
- van der Waal, I. Knowledge about oral leukoplakia for use at different levels of expertise, including patients. Oral Dis. 2018, 24, 174–178. [Google Scholar] [CrossRef]
- Mello, F.W.; Miguel, A.F.P.; Dutra, K.L.; Porporatti, A.L.; Warnakulasuriya, S.; Guerra, E.N.S.; Rivero, E.R.C. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J. Oral Pathol. Med. 2018, 47, 633–640. [Google Scholar] [CrossRef]
- Lee, J.J.; Hung, H.C.; Cheng, S.J.; Chen, Y.J.; Chiang, C.P.; Liu, B.Y.; Jeng, J.H.; Chang, H.H.; Kuo, Y.S.; Lan, W.H.; et al. Carcinoma and dysplasia in oral leukoplakias in Taiwan: Prevalence and risk factors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2006, 101, 472–480. [Google Scholar] [CrossRef]
- Warnakulasuriya, S.; Ariyawardana, A. Malignant transformation of oral leukoplakia: A systematic review of observational studies. J. Oral Pathol. Med. 2016, 45, 155–166. [Google Scholar] [CrossRef]
- Shearston, K.; Fateh, B.; Tai, S.; Hove, D.; Farah, C.S. Malignant transformation rate of oral leukoplakia in an Australian population. J. Oral Pathol. Med. 2019, 48, 530–537. [Google Scholar] [CrossRef]
- Bánóczy, J. Follow-up studies in oral leukoplakia. J. Maxillofac. Surg. 1977, 5, 69–75. [Google Scholar] [CrossRef]
- Bánóczy, J.; Sugár, L. Longitudinal studies in oral leukoplakias. J. Oral Pathol. 1972, 1, 265–272. [Google Scholar] [CrossRef] [PubMed]
- Schepman, K.P.; van der Meij, E.H.; Smeele, L.E.; van der Waal, I. Malignant transformation of oral leukoplakia: A follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998, 34, 270–275. [Google Scholar] [CrossRef]
- Silverman, S., Jr.; Gorsky, M.; Lozada, F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984, 53, 563–568. [Google Scholar]
- Aguirre-Urizar, J.M.; Lafuente-Ibanez de Mendoza, I.; Warnakulasuriya, S. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years. Oral Dis. 2021. [Google Scholar] [CrossRef] [PubMed]
- Kusiak, A.; Maj, A.; Cichonska, D.; Kochanska, B.; Cydejko, A.; Swietlik, D. The Analysis of the Frequency of Leukoplakia in Reference of Tobacco Smoking among Northern Polish Population. Int. J. Environ. Res. Public Health 2020, 17, 6919. [Google Scholar] [CrossRef]
- Wang, T.Y.; Chiu, Y.W.; Chen, Y.T.; Wang, Y.H.; Yu, H.C.; Yu, C.H.; Chang, Y.C. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study. J. Formos. Med. Assoc. 2018, 117, 374–380. [Google Scholar] [CrossRef]
- Holmstrup, P.; Vedtofte, P.; Reibel, J.; Stoltze, K. Oral premalignant lesions: Is a biopsy reliable? J. Oral Pathol. Med. 2007, 36, 262–266. [Google Scholar] [CrossRef] [PubMed]
- Yang, S.W.; Lee, Y.S.; Chang, L.C.; Hsieh, T.Y.; Chen, T.A. Outcome of excision of oral erythroplakia. Br. J. Oral Maxillofac. Surg. 2015, 53, 142–147. [Google Scholar] [CrossRef]
- Yang, S.W.; Tsai, C.N.; Lee, Y.S.; Chen, T.A. Treatment outcome of dysplastic oral leukoplakia with carbon dioxide laser—Emphasis on the factors affecting recurrence. J. Oral Maxillofac. Surg. 2011, 69, e78–e87. [Google Scholar] [CrossRef]
- Yang, S.W.; Wu, C.J.; Lee, Y.S.; Chen, T.A.; Tsai, C.N. Postoperative recurrence as an associated factor of malignant transformation of oral dysplastic leukoplakia. ORL J. Otorhinolaryngol. Relat. Spec. 2010, 72, 280–290. [Google Scholar] [CrossRef] [PubMed]
- Warnakulasuriya, S.; Johnson, N.W.; van der Waal, I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J. Oral Pathol. Med. 2007, 36, 575–580. [Google Scholar] [CrossRef] [PubMed]
- Awadallah, M.; Idle, M.; Patel, K.; Kademani, D. Management update of potentially premalignant oral epithelial lesions. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2018, 125, 628–636. [Google Scholar] [CrossRef] [Green Version]
- Amagasa, T.; Yamashiro, M.; Uzawa, N. Oral premalignant lesions: From a clinical perspective. Int. J. Clin. Oncol. 2011, 16, 5–14. [Google Scholar] [CrossRef] [PubMed]
- Yang, S.W. Oral Erythroplakia: An Update and Literature Review of Clinicopathological Characteristics and Treatment Outcomes. Int. J. Head Neck Sci. 2019, 3, 16–22. [Google Scholar]
- González-Moles, M.Á.; Ramos-García, P.; Warnakulasuriya, S. A Scoping Review on Gaps in the Diagnostic Criteria for Proliferative Verrucous Leukoplakia: A Conceptual Proposal and Diagnostic Evidence-Based Criteria. Cancers 2021, 13, 3669. [Google Scholar] [CrossRef]
- Ramos-Garcia, P.; Gonzalez-Moles, M.A.; Mello, F.W.; Bagan, J.V.; Warnakulasuriya, S. Malignant transformation of oral proliferative verrucous leukoplakia: A systematic review and meta-analysis. Oral Dis. 2021. [Google Scholar] [CrossRef]
- Villa, A.; Menon, R.S.; Kerr, A.R.; De Abreu Alves, F.; Guollo, A.; Ojeda, D.; Woo, S.B. Proliferative leukoplakia: Proposed new clinical diagnostic criteria. Oral Dis. 2018, 24, 749–760. [Google Scholar] [CrossRef] [PubMed]
- Carrard, V.C.; Brouns, E.R.; van der Waal, I. Proliferative verrucous leukoplakia; a critical appraisal of the diagnostic criteria. Med. Oral Patol. Oral Cir. Bucal 2013, 18, e411–e413. [Google Scholar] [CrossRef]
- Cerero-Lapiedra, R.; Balade-Martinez, D.; Moreno-Lopez, L.A.; Esparza-Gomez, G.; Bagan, J.V. Proliferative verrucous leukoplakia: A proposal for diagnostic criteria. Med. Oral Patol. Oral Cir. Bucal 2010, 15, e839–e845. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hansen, L.S.; Olson, J.A.; Silverman, S., Jr. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg. Oral Med. Oral Pathol. 1985, 60, 285–298. [Google Scholar] [CrossRef]
- Wen, C.P.; Levy, D.T.; Cheng, T.Y.; Hsu, C.C.; Tsai, S.P. Smoking behaviour in Taiwan, 2001. Tob. Control 2005, 14 (Suppl. 1), i51–i55. [Google Scholar] [CrossRef] [Green Version]
- Ko, Y.C.; Huang, Y.L.; Lee, C.H.; Chen, M.J.; Lin, L.M.; Tsai, C.C. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J. Oral Pathol. Med. 1995, 24, 450–453. [Google Scholar] [CrossRef] [PubMed]
- Chien, C.Y.; Su, C.Y.; Fang, F.M.; Huang, H.Y.; Chuang, H.C.; Chen, C.M.; Huang, C.C. Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol. 2008, 44, 174–179. [Google Scholar] [CrossRef] [PubMed]
- Dawson, D.A. Drinking as a risk factor for sustained smoking. Drug Alcohol Depend. 2000, 59, 235–249. [Google Scholar] [CrossRef]
- Murphy, K.L.; Herzog, T.A. Sociocultural Factors that Affect Chewing Behaviors among Betel Nut Chewers and Ex-Chewers on Guam. Hawaii J. Med. Public Health 2015, 74, 406–411. [Google Scholar]
- Warnakulasuriya, S.; Reibel, J.; Bouquot, J.; Dabelsteen, E. Oral epithelial dysplasia classification systems: Predictive value, utility, weaknesses and scope for improvement. J. Oral Pathol. Med. 2008, 37, 127–133. [Google Scholar] [CrossRef]
- Ishii, J.; Fujita, K.; Komori, T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol. 2003, 39, 759–769. [Google Scholar] [CrossRef]
- Schoenfeld, D.A. Sample-size formula for the proportional-hazards regression model. Biometrics 1983, 39, 499–503. [Google Scholar] [CrossRef] [Green Version]
- Schisterman, E.F.; Perkins, N.J.; Liu, A.; Bondell, H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 2005, 16, 73–81. [Google Scholar] [CrossRef] [PubMed]
- Simel, D.L.; Samsa, G.P.; Matchar, D.B. Likelihood ratios with confidence: Sample size estimation for diagnostic test studies. J. Clin. Epidemiol. 1991, 44, 763–770. [Google Scholar] [CrossRef]
- Villa, A.; Sonis, S. Oral leukoplakia remains a challenging condition. Oral Dis. 2018, 24, 179–183. [Google Scholar] [CrossRef] [PubMed]
- Dost, F.; Le Cao, K.A.; Ford, P.J.; Farah, C.S. A retrospective analysis of clinical features of oral malignant and potentially malignant disorders with and without oral epithelial dysplasia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2013, 116, 725–733. [Google Scholar] [CrossRef]
- Ramos-Garcia, P.; Roca-Rodriguez, M.D.M.; Aguilar-Diosdado, M.; Gonzalez-Moles, M.A. Diabetes mellitus and oral cancer/oral potentially malignant disorders: A systematic review and meta-analysis. Oral Dis. 2021, 27, 404–421. [Google Scholar] [CrossRef]
- Gong, Y.; Wei, B.; Yu, L.; Pan, W. Type 2 diabetes mellitus and risk of oral cancer and precancerous lesions: A meta-analysis of observational studies. Oral Oncol. 2015, 51, 332–340. [Google Scholar] [CrossRef] [PubMed]
- Veitz-Keenan, A.; Silvestre Calle, T.D.; Bergamini, M. Limited Evidence Suggests Metformin Might Be Beneficial to Reduce Head and Neck Cancer Risk and Increase Overall Survival, While Any Benefit With Antiinflammatory Drugs Is Inconsistent. J. Evid. Based Dent. Pract. 2019, 19, 298–300. [Google Scholar] [CrossRef] [PubMed]
- Porter, S.; Gueiros, L.A.; Leao, J.C.; Fedele, S. Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2018, 125, 603–611. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jacob, B.J.; Straif, K.; Thomas, G.; Ramadas, K.; Mathew, B.; Zhang, Z.F.; Sankaranarayanan, R.; Hashibe, M. Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol. 2004, 40, 697–704. [Google Scholar] [CrossRef]
- Hamadah, O.; Goodson, M.L.; Thomson, P.J. Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions. Br. J. Oral Maxillofac. Surg. 2010, 48, 503–506. [Google Scholar] [CrossRef]
- Saito, T.; Sugiura, C.; Hirai, A.; Notani, K.; Totsuka, Y.; Shindoh, M.; Kohgo, T.; Fukuda, H. High malignant transformation rate of widespread multiple oral leukoplakias. Oral Dis. 1999, 5, 15–19. [Google Scholar] [CrossRef]
- Thomson, P.J.; Goodson, M.L.; Cocks, K.; Turner, J.E. Interventional laser surgery for oral potentially malignant disorders: A longitudinal patient cohort study. Int. J. Oral Maxillofac. Surg. 2017, 46, 337–342. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dost, F.; Le Cao, K.; Ford, P.J.; Ades, C.; Farah, C.S. Malignant transformation of oral epithelial dysplasia: A real-world evaluation of histopathologic grading. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2014, 117, 343–352. [Google Scholar] [CrossRef] [Green Version]
- Mustafa, M.B.; Hassan, M.O.; Alhussein, A.; Mamoun, E.; El Sheikh, M.; Suleiman, A.M. Oral leukoplakia in the Sudan: Clinicopathological features and risk factors. Int. Dent. J. 2019, 69, 428–435. [Google Scholar] [CrossRef] [PubMed]
- Lodi, G.; Porter, S. Management of potentially malignant disorders: Evidence and critique. J. Oral Pathol. Med. 2008, 37, 63–69. [Google Scholar] [CrossRef] [PubMed]
- Chandu, A.; Smith, A.C. The use of CO2 laser in the treatment of oral white patches: Outcomes and factors affecting recurrence. Int. J. Oral Maxillofac. Surg. 2005, 34, 396–400. [Google Scholar] [CrossRef]
- Yang, S.W.; Lee, Y.S.; Chang, L.C.; Yang, C.H.; Luo, C.M.; Wu, P.W. Oral tongue leukoplakia: Analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation. Clin. Oral Investig. 2021, 25, 4045–4058. [Google Scholar] [CrossRef]
- Yang, S.W.; Lee, Y.S.; Chang, L.C.; Hwang, C.C.; Chen, T.A. Clinicopathological characteristics and treatment outcomes of oral leukoplakia by carbon dioxide laser excision in the elderly patients. Head Neck 2020, 42, 1014–1023. [Google Scholar] [CrossRef] [Green Version]
- Brouns, E.; Baart, J.; Karagozoglu, K.; Aartman, I.; Bloemena, E.; van der Waal, I. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 2014, 20, e19–e24. [Google Scholar] [CrossRef]
- Holmstrup, P.; Vedtofte, P.; Reibel, J.; Stoltze, K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006, 42, 461–474. [Google Scholar] [CrossRef]
- Liao, C.T.; Wen, Y.W.; Yang, L.Y.; Lee, S.R.; Ng, S.H.; Liu, T.W.; Tsai, S.T.; Tsai, M.H.; Lin, J.C.; Chen, P.R.; et al. Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas. Oral Oncol. 2017, 67, 95–102. [Google Scholar] [CrossRef]
- Ord, R.A.; Isaiah, A.; Dyalram, D.; Lubek, J.E. Is Long-Term Follow-Up Mandatory for Stage I Oral Tongue Cancer? J. Oral Maxillofac. Surg. 2018, 76, 2676–2683. [Google Scholar] [CrossRef]
- Yang, S.W.; Lee, Y.S.; Chang, L.C.; Yang, C.H.; Luo, C.M. An anatomical perspective on clinicopathological characteristics and treatment outcomes of dorsal and ventrolateral tongue leukoplakia after carbon dioxide laser surgery. BMC Oral Health 2021, 21, 45. [Google Scholar]
- Evren, I.; Brouns, E.R.; Wils, L.J.; Poell, J.B.; Peeters, C.F.W.; Brakenhoff, R.H.; Bloemena, E.; de Visscher, J. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study. Oral Oncol. 2020, 110, 105014. [Google Scholar] [CrossRef]
- Brouns, E.R.; Baart, J.A.; Karagozoglu, K.H.; Aartman, I.H.; Bloemena, E.; van der Waal, I. Treatment results of CO2 laser vaporisation in a cohort of 35 patients with oral leukoplakia. Oral Dis. 2013, 19, 212–216. [Google Scholar] [CrossRef] [PubMed]
- van der Hem, P.S.; Nauta, J.M.; van der Wal, J.E.; Roodenburg, J.L. The results of CO2 laser surgery in patients with oral leukoplakia: A 25 year follow up. Oral Oncol. 2005, 41, 31–37. [Google Scholar] [CrossRef] [PubMed]
- Lind, P.O. Malignant transformation in oral leukoplakia. Scand. J. Dent. Res. 1987, 95, 449–455. [Google Scholar] [CrossRef]
- Hogewind, W.F.; van der Kwast, W.A.; van der Waal, I. Oral leukoplakia, with emphasis on malignant transformation. A follow-up study of 46 patients. J. CranioMaxillofac. Surg. 1989, 17, 128–133. [Google Scholar] [CrossRef]
- Sundberg, J.; Korytowska, M.; Holmberg, E.; Bratel, J.; Wallstrom, M.; Kjellstrom, E.; Blomgren, J.; Kovacs, A.; Ohman, J.; Sand, L.; et al. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study. PLoS ONE 2019, 14, e0225682. [Google Scholar] [CrossRef] [PubMed]
- Rautava, J.; Luukkaa, M.; Heikinheimo, K.; Alin, J.; Grenman, R.; Happonen, R.P. Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival. Oral Oncol. 2007, 43, 911–919. [Google Scholar] [CrossRef] [PubMed]
- Slaughter, D.P.; Southwick, H.W.; Smejkal, W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 6, 963–968. [Google Scholar] [CrossRef]
- Farah, C.S.; Fox, S.A. Dysplastic oral leukoplakia is molecularly distinct from leukoplakia without dysplasia. Oral Dis. 2019, 25, 1715–1723. [Google Scholar] [CrossRef] [PubMed]
Factors | Male (n = 412) | Female (n = 73) | Odds Ratio | CI 95% | Fisher’s Exact p Value | |
---|---|---|---|---|---|---|
Age (yr), mean ± stand deviation: 53.03 ± 11.87, median: 53.0 | ns | |||||
≤65 | 354 | 58 | 1.0 | |||
>65 | 58 | 15 | 1.58 | 0.84–2.97 | ||
Body mass index * | 25.86 ± 3.75 | 24.87 ± 4.92 | 0.93 | 0.87–1.0 | ns ** | |
Cigarette smoking † | <0.0001 | |||||
Non-smoker | 62 | 47 | 1.0 | |||
Ex-smoker | 154 | 9 | 0.077 | 0.036–0.17 | ||
Current smoker | 195 | 17 | 0.12 | 0.062–0.21 | ||
Alcohol drinking ‡ | <0.0001 | |||||
Non-drinker | 227 | 66 | 1.0 | |||
Ex-drinker | 107 | 6 | 0.19 | 0.081–0.46 | ||
Current drinker | 77 | 1 | 0.045 | 0.0061–0.33 | ||
Betel quid chewing § | <0.0001 | |||||
Non-chewer | 171 | 66 | 1.0 | |||
Ex-chewer | 211 | 5 | 0.061 | 0.024–0.16 | ||
Current chewer | 29 | 2 | 0.18 | 0.042–0.77 | ||
Candida infection | ns | |||||
No | 375 | 67 | 1.0 | |||
Yes | 37 | 6 | 0.91 | 0.37–2.23 | ||
Multifocal disease | ns | |||||
No | 272 | 54 | 1.0 | |||
Yes | 140 | 19 | 0.68 | 0.39–1.20 | ||
Location (Tongue and mouth floor) | 0.033 | |||||
No | 329 | 50 | 1.0 | |||
Yes | 83 | 23 | 1.82 | 1.05–3.16 | ||
Location (Buccal and other sites except tongue and mouth floor) | 0.0001 | |||||
No | 26 | 16 | 1.0 | |||
Yes | 386 | 57 | 0.24 | 0.12–0.47 | ||
Location: All subsites in the oral cavity ‖ | ||||||
Buccal | 331 | 44 | 0.37 | 0.22–0.63 | 0.0003 | |
Tongue | 89 | 27 | 2.13 | 1.25–3.62 | 0.0054 | |
Mouth floor | 4 | 1 | 1.42 | 0.16–12.86 | ns | |
Retromolar | 85 | 16 | 1.08 | 0.59–1.97 | ns | |
Hard palate | 20 | 3 | 0.84 | 0.24–2.90 | ns | |
Gum | 48 | 3 | 0.33 | 0.099–1.07 | ns | |
Labial | 20 | 5 | 1.44 | 0.52–3.97 | ns | |
Diabetes mellitus ¶ | ||||||
No | 326 | 57 | 1.0 | ns | ||
Yes | 83 | 16 | 1.1 | 0.60–2.02 | ||
Metformin treatment # | ns | |||||
No | 340 | 61 | 1.0 | |||
Yes | 68 | 12 | 0.98 | 0.50–1.93 | ||
Clinical morphology | ns | |||||
Homogeneous | 274 | 44 | 1.0 | |||
Non-homogeneous | 138 | 29 | 1.31 | 0.78–2.18 | ||
Pathology | ns | |||||
Squamous hyperplasia | 109 | 25 | 1.0 | |||
Mild dysplasia | 192 | 27 | 0.61 | 0.34–1.11 | ||
Moderate dysplasia | 63 | 11 | 0.76 | 0.35–1.65 | ||
Severe dysplasia | 48 | 10 | 0.91 | 0.40–2.04 | ||
Area of oral leukoplakia (cm2) | 2.72 ± 3.29 | 2.78 ± 3.38 | 1.01 | 0.93–1.08 | ns ** | |
Follow-up time (year) | 5.39 ± 3.78 | 5.91 ± 4.67 | 1.03 | 0.97–1.10 | ns ** |
Factors | Male (n = 412) | Female (n = 73) | OR | CI 95% | p Value | HR * | CI 95% | p Value | |
---|---|---|---|---|---|---|---|---|---|
Postoperative recurrence | ns | ||||||||
No | 287 | 49 | 1.0 | ||||||
Yes | 125 | 24 | 0.98 | 0.63–1.54 | |||||
Malignant transformation | ns | ||||||||
No | 386 | 67 | 1.0 | ||||||
Yes | 26 | 6 | 1.07 | 0.41–2.75 | |||||
Postoperative recurrence rate (%) | 30.34% | 32.88% | 1.12 | 0.66–1.91 | ns | ||||
Time period for development of malignant transformation (year) | 3.58 ± 3.43 | 3.95 ± 3.07 | 1.03 | 0.80–1.33 | ns | ||||
Cumulative malignant transformation rate (%) | 6.31% | 8.22% | 1.33 | 0.53–3.35 | ns | ||||
Annual transformation rate (%) † | 1.76% | 2.08% | ns |
Variable | Recurrence | Log-Rank Tests | Cox Proportional Regression Analysis | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Confidence Interval 95% | Confidence Interval 95% | ||||||||||
No (n = 49) | Yes (n = 24) | Hazard Ratio | Upper | Lower | p Value | Hazard Ratio | Upper | Lower | p Value | ||
Age (yr), mean ± standard deviation: 56.73 ± 12.19, median: 58.0 | 1.39 | 0.47 | 4.14 | 0.75 | 1.01 | 0.96 | 1.05 | 0.78 | |||
≤65 | 39 | 19 | |||||||||
>65 | 10 | 5 | |||||||||
Body mass index * | 1.19 | 0.52 | 2.70 | 0.84 | 1.00 | 0.996 | 1.002 | 0.55 | |||
≤24 | 22 | 10 | |||||||||
>24 | 24 | 13 | |||||||||
Cigarette smoking | 1.09 | 0.47 | 2.55 | 0.99 | 0.50 | 0.13 | 1.94 | 0.32 | |||
Non-smoker | 32 | 15 | |||||||||
Ex-smoker | 7 | 2 | |||||||||
Current smoker | 10 | 7 | |||||||||
Alcohol drinking | 2.07 | 0.55 | 7.85 | 0.47 | 1.24 | 0.042 | 36.34 | 0.90 | |||
Non-drinker | 46 | 20 | |||||||||
Ex-drinker | 3 | 3 | |||||||||
Current drinker | 0 | 1 | |||||||||
Betel quid chewing | 1.44 | 0.43 | 4.81 | 0.78 | 1.29 | 0.05 | 33.01 | 0.88 | |||
Non-chewer | 46 | 20 | |||||||||
Ex-chewer | 2 | 3 | |||||||||
Current chewer | 1 | 1 | |||||||||
Candida infection | 1.21 | 0.38 | 3.87 | 0.98 | 1.16 | 0.19 | 7.04 | 0.88 | |||
No | 47 | 20 | |||||||||
Yes | 2 | 4 | |||||||||
Multifocal disease | 1.89 | 0.78 | 4.57 | 0.24 | 1.48 | 0.47 | 4.68 | 0.50 | |||
Single lesion | 40 | 14 | |||||||||
Multiple sites of lesions | 9 | 10 | |||||||||
Location (Tongue and mouth floor) | 0.77 | 0.33 | 1.77 | 0.69 | 0.12 | 0.11 | 1.29 | 0.08 | |||
No | 34 | 16 | |||||||||
Yes | 15 | 8 | |||||||||
Location (Buccal and other sites except tongue and mouth floor) | 1.82 | 0.74 | 4.47 | 0.28 | 0.14 | 0.10 | 2.00 | 0.15 | |||
No | 12 | 4 | |||||||||
Yes | 37 | 20 | |||||||||
Diabetes mellitus | 1.75 | 0.65 | 4.77 | 0.4 | 1.46 | 0.81 | 26.28 | 0.80 | |||
No | 40 | 17 | |||||||||
Yes | 9 | 7 | |||||||||
Metformin treatment | 1.68 | 0.58 | 4.82 | 0.49 | 2.87 | 0.13 | 47.32 | 0.55 | |||
No | 43 | 18 | |||||||||
Yes | 6 | 6 | |||||||||
Morphology | 2.41 | 0.99 | 5.85 | 0.085 | 2.10 | 0.68 | 6.45 | 0.2 | |||
Homogeneous | 32 | 12 | |||||||||
Non-homogeneous | 17 | 12 | |||||||||
Pathology | 1.67 | 0.70 | 4.00 | 0.35 | 0.65 | 0.20 | 2.15 | 0.48 | |||
Low risk lesions † | 38 | 14 | |||||||||
High risk lesions ‡ | 11 | 10 | |||||||||
Area of oral leukoplakia (cut-off value: 1.755 cm2) | 4.12 | 1.82 | 9.34 | 0.001 | 1.27 | 1.08 | 1.49 | 0.04 | |||
≤1.755 | 34 | 6 | |||||||||
>1.755 | 15 | 18 |
Variable | Malignant Transformation | Log-Rank Tests | Cox Proportional Regression Analysis | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Confidence interval 95% | Confidence Interval 95% | ||||||||||
No (n = 67) | Yes (n = 6) | Hazard Ratio | Upper | Lower | p Value | Hazard Ratio | Upper | Lower | p Value | ||
Age (yr) | 0.69 | 0.10 | 4.70 | 0.91 | 0.41 | 0.026 | 6.44 | 0.52 | |||
≤65 | 53 | 5 | |||||||||
>65 | 14 | 1 | |||||||||
Body mass index * | 1.45 | 0.25 | 8.55 | 0.97 | NA | NA | NA | NA | |||
≤24 | 30 | 2 | |||||||||
>24 | 34 | 3 | |||||||||
Cigarette smoking | 0.40 | 0.08 | 2.11 | 0.51 | NA | NA | NA | NA | |||
Non-smoker | 42 | 5 | |||||||||
Ex-smoker | 9 | 0 | |||||||||
Current smoker | 16 | 1 | |||||||||
Alcohol drinking | 0.31 | 0.03 | 3.21 | 0.70 | NA | NA | NA | NA | |||
Non-drinker | 60 | 6 | |||||||||
Ex-drinker | 6 | 0 | |||||||||
Current drinker | 1 | 0 | |||||||||
Betel quid chewing | 0.31 | 0.03 | 3.23 | 0.70 | NA | NA | NA | NA | |||
Non-chewer | 60 | 6 | |||||||||
Ex-chewer | 5 | 0 | |||||||||
Current chewer | 2 | 0 | |||||||||
Candida infection | 1.75 | 0.14 | 22.47 | 0.83 | NA | NA | NA | NA | |||
No | 62 | 5 | |||||||||
Yes | 5 | 1 | |||||||||
Multifocal disease | 1.05 | 0.19 | 5.94 | 0.70 | 0.07 | 0.00 | 1.36 | 0.08 | |||
Single lesion | 50 | 4 | |||||||||
Multiple lesions | 17 | 2 | |||||||||
Location (Tongue and mouth floor) | 1.90 | 0.35 | 10.16 | 0.75 | 3.33 | 0.044 | 249.28 | 0.59 | |||
No | 47 | 3 | |||||||||
Yes | 20 | 3 | |||||||||
Location (Buccal and other sites except tongue and mouth floor) | 0.67 | 0.11 | 4.20 | 0.97 | 1.43 | 0.013 | 152.81 | 0.88 | |||
No | 14 | 2 | |||||||||
Yes | 53 | 4 | |||||||||
Diabetes mellitus | 1.90 | 0.28 | 13.04 | 0.87 | NA | NA | NA | NA | |||
No | 53 | 4 | |||||||||
Yes | 14 | 2 | |||||||||
Metformin treatment | 0.70 | 0.10 | 4.78 | 0.90 | 0.60 | 0.033 | 11.05 | 0.73 | |||
No | 56 | 5 | |||||||||
Yes | 11 | 1 | |||||||||
Morphology | 9.81 | 1.76 | 54.73 | 0.03 | 4.53 | 0.41 | 50.65 | 0.22 | |||
Homogeneous | 43 | 1 | |||||||||
Non-homogeneous | 24 | 5 | |||||||||
Pathology | 7.30 | 1.21 | 44.06 | 0.09 | 6.07 | 0.33 | 112.57 | 0.23 | |||
Low risk lesions † | 50 | 2 | |||||||||
High risk lesions ‡ | 17 | 4 | |||||||||
Recurrence | 11.92 | 2.07 | 68.67 | 0.02 | 14.99 | 0.80 | 280.11 | 0.07 | |||
No | 48 | 1 | |||||||||
Yes | 19 | 5 | |||||||||
Area of oral leukoplakia (cm2) | 2.58 ± 2.99 | 5.06 ± 6.31 | NA | NA | NA | NA | 1.04 | 0.71 | 1.54 | 0.83 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yang, S.-W.; Lee, Y.-S.; Wu, P.-W.; Chang, L.-C.; Hwang, C.-C. A Retrospective Cohort Study of Oral Leukoplakia in Female Patients—Analysis of Risk Factors Related to Treatment Outcomes. Int. J. Environ. Res. Public Health 2021, 18, 8319. https://doi.org/10.3390/ijerph18168319
Yang S-W, Lee Y-S, Wu P-W, Chang L-C, Hwang C-C. A Retrospective Cohort Study of Oral Leukoplakia in Female Patients—Analysis of Risk Factors Related to Treatment Outcomes. International Journal of Environmental Research and Public Health. 2021; 18(16):8319. https://doi.org/10.3390/ijerph18168319
Chicago/Turabian StyleYang, Shih-Wei, Yun-Shien Lee, Pei-Wen Wu, Liang-Che Chang, and Cheng-Cheng Hwang. 2021. "A Retrospective Cohort Study of Oral Leukoplakia in Female Patients—Analysis of Risk Factors Related to Treatment Outcomes" International Journal of Environmental Research and Public Health 18, no. 16: 8319. https://doi.org/10.3390/ijerph18168319
APA StyleYang, S. -W., Lee, Y. -S., Wu, P. -W., Chang, L. -C., & Hwang, C. -C. (2021). A Retrospective Cohort Study of Oral Leukoplakia in Female Patients—Analysis of Risk Factors Related to Treatment Outcomes. International Journal of Environmental Research and Public Health, 18(16), 8319. https://doi.org/10.3390/ijerph18168319